About Cefaly
Cefaly is a company based in Seraing (Belgium) founded in 2004 by Pierre RIGAUX was acquired by DW Management Services in June 2019. Cefaly operates in a competitive market with competitors including ElectroCore, ShiraTronics, eNeura, Salvia BioElectronics and Zosano Pharma, among others.
- Headquarter Seraing, Belgium
- Founders Pierre RIGAUX
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cefaly Technology
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
DW Management Services
(Jun 27, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cefaly
Detailed funding history for Cefaly
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Cefaly
Cefaly has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include DW Management Services.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for Cefaly
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cefaly
Investment portfolio details for Cefaly
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cefaly
Detailed financials for Cefaly
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cefaly Comparisons
Peer comparison for Cefaly
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cefaly
Cefaly operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ElectroCore, ShiraTronics, eNeura, Salvia BioElectronics and Zosano Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive vagus nerve stimulation devices are developed for headache treatments.
|
|
| Locked | Locked | Locked |
Neuromodulation devices for migraine and chronic disease treatment are developed.
|
|
| Locked | Locked | Locked |
Transcranial magnetic stimulation devices for migraine treatment are developed.
|
|
| Locked | Locked | Locked |
Bioelectronic solutions for migraines and neurological disorders are developed.
|
|
| Locked | Locked | Locked |
Develops innovative transdermal drug delivery technologies for various therapeutic applications.
|
Detailed competitors of Cefaly
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cefaly
Complete news archive for Cefaly
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cefaly
Cefaly was founded in 2004.
Cefaly is headquartered in Seraing, Belgium. It is registered at Seraing, Liege, Belgium.
Jen Trainor McDermott is the current CEO of Cefaly.
Cefaly was founded in 2004 in Seraing, Belgium, where neurostimulation devices are developed for migraine and headache management. Operations center on non-invasive treatments that aim to reduce reliance on medications. The company operates in the medical device sector, with services focused on external trigeminal nerve stimulation. Leadership includes CEO Jen Trainor McDermott and co-founder Pierre RIGAUX, supporting global distribution from its Belgian base.
Cefaly's top competitors include Salvia BioElectronics, ShiraTronics and ElectroCore.
Cefaly has 1 investor. Key investors include DW Management Services.